Researchers Receive Grants From National Comprehensive Cancer Network Oncology Research Program Funded Through AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO)/Astellas Pharma Inc. (YPH.BE) Collaboration
10/15/2012 10:19:24 AM
More...
|
National Comprehensive Cancer Network Appoints Dr. Robert Carlson as CEO
9/24/2012 7:35:24 AM
More...
|
Researchers Receive Grants From National Comprehensive Cancer Network Oncology Research Program Funded Through GlaxoSmithKline (GSK)
9/6/2012 9:58:59 AM
More...
|
Researchers Receive Grants From National Comprehensive Cancer Network Oncology Research Program Funded Through Boehringer Ingelheim Corporation
9/4/2012 10:38:04 AM
More...
|
Highlights of the National Comprehensive Cancer Network 17th Annual Conference Include Presentations on Lung Cancer Screening, Melanoma, and Non-Hodgkin’s Lymphomas
3/29/2012 7:28:10 AM
More...
|
National Comprehensive Cancer Network Presents New Guidelines for Acute Lymphoblastic Leukemia
3/21/2012 6:25:55 AM
More...
|
National Comprehensive Cancer Network to Hold 17th Annual Conference: Sam Donaldson and Clifford Goodman Lead Roundtable Discussions on Critical Issues in Cancer Care
3/13/2012 6:53:27 AM
More...
|
National Comprehensive Cancer Network Collaborates with AVEO Pharmaceuticals, Inc. (AVEO) and Astellas Pharma Inc. (YPH.BE) on Innovative Cancer Research
2/17/2012 6:45:06 AM
More...
|
National Comprehensive Cancer Network Receives $2 Million in Oncology Research Funding from Boehringer Ingelheim Corporation to Investigate Afatinib in Solid Tumors
11/10/2011 8:38:39 AM
More...
|
National Comprehensive Cancer Network Guidelines Emphasize Patient Preference as Key to Selection of Maintenance Therapy in Follicular Lymphoma
9/15/2011 9:42:43 AM
More...
|
|